Lambert-Eaton myasthenic syndrome in childhood.

Kostera-Pruszczyk, A; Ryniewicz, B; Rowinska-Marcinska, K; Dutkiewicz, M; Kaminska, A

Kostera-Pruszczyk, A; Ryniewicz, B; Rowinska-Marcinska, K; Dutkiewicz, M; Kaminska, A.

Affiliation

Kostera-Pruszczyk A; Department of Neurology, Medical University of Warsaw, Poland. akostera@amwaw.edu.pl

Eur J Paediatr Neurol ; 13(2): 194-6, 2009 Mar.

Article in En | MEDLINE | ID: mdl-18585938

Subject(s)

Calcium Channels, P-Type/immunology; Lambert-Eaton Myasthenic Syndrome/diagnosis; Lambert-Eaton Myasthenic Syndrome/immunology; Autoantibodies/metabolism; Azathioprine/therapeutic use; Child; Humans; Immunosuppressive Agents/therapeutic use; Lambert-Eaton Myasthenic Syndrome/drug therapy; Lambert-Eaton Myasthenic Syndrome/physiopathology; Male; Muscle Weakness/etiology; Muscle Weakness/physiopathology; Prednisone/therapeutic use; Radioimmunoassay

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lambert-Eaton Myasthenic Syndrome / Calcium Channels, P-Type Type of study: Etiology_studies Limits: Child / Humans / Male Language: En Journal: Eur J Paediatr Neurol Journal subject: NEUROLOGIA / PEDIATRIA Year: 2009 Document type: Article Affiliation country: Poland Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google